The Breast Implant Market To Show Constructive Disruption With ~ US$ 1.7 Billion

Posted by Ashish on January 19th, 2021

Worldwide sales of breast implants is expected to reach ~ US$ 1.8 Bn by the end of 2019 and is forecasted to reach ~ US$ 1.7 Bn by the end of 2029, unveils the new research study by Persistence Market Research (PMR). According to the report, the breast implants market is estimated to grow by ~3% Y-O-Y by the end of 2020, primarily influenced by the recent advancements in the breast implants market.

According to the report, greater emphasis on physical appearance of the breasts and rise in global per capita disposable income of women have led to more number of women undergoing breast implants procedures globally. Also, manufacturers of breast implants are focusing on introducing wide range of breast implants in terms of sizes, shapes, and texture, which is expected to upsurge the growth of the global breast implants market over the forecast period.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/10972

Company Profiles

• Allergan, Plc (Actavis Plc)
• Mentor Worldwide LLC. (Johnson & Johnson Services, Inc.)
• GC Aesthetics plc
• Sientra, Inc.,
• Groupe Sebbin SAS
• Polytech Health & Aesthetics GmbH
• Establishment Labs S.A.
• HansBiomed Co., Ltd
• CEREPLAS

Combined Breast Augmentation to Create Scope for the Market Growth

Breast augmentation procedures in combination with breast lifting have received much attention among women in recent years to enhance the appearance of their breasts in terms of shape and size particularly those who are concerned with deflated or sagging breast appearance. While a breast lift procedure will elevate and reshape breasts, breast implants will add volume to their breasts.

Also combined procedural cost is less when compared to the individual procedure leading to more number of women opting for both procedures at one time. These factors are anticipated to aid the growth of the breast implants market over the forecast period.